Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer. - Lee CU; Yeom SY; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Seo SI (The world journal of men's health, 2025)